Evidence map›Paper›PMID 24920905›Full record

ArticleInternational journal of nanomedicine2014

Calcifying nanoparticles promote mineralization in vascular smooth muscle cells: implications for atherosclerosis.

Larry W Hunter, Jon E Charlesworth, Sam Yu, John C Lieske, Virginia M Miller

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Calciprotein Particles: Balancing Mineral Homeostasis and Vascular Pathology.Arteriosclerosis, thrombosis, and vascular biology · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Larry W HunterDepartment of Surgery, Mayo Clinic, Rochester, MN, USA.
Jon E CharlesworthDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Sam YuLincoln University, Christchurch, New Zealand ; Izon Science Ltd., Christchurch, New Zealand.
John C LieskeDepartment of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Virginia M MillerDepartment of Surgery, Mayo Clinic, Rochester, MN, USA ; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.
Mayo Clinic · USLincoln University · NZMayo Clinic in Arizona · US

Funding

Nanoparticles and Arterial DiseaseR21HL088988 · NHLBI · MAYO CLINIC ROCHESTER · PI MILLER, VIRGINIA M · 2008 to 2009
$416k
NHLBI NIH HHS R21 HL088988NHLBI NIH HHS R21 HL88988
6 · The paper itself

Abstract

backgroundNano-sized complexes of calcium phosphate mineral and proteins (calcifying nanoparticles [CNPs]) serve as mineral chaperones. Thus, CNPs may be both a result and cause of soft tissue calcification processes. This study determined if CNPs could augment calcification of arterial vascular smooth muscle cells in vitro.

methodsCNPs 210 nm in diameter were propagated in vitro from human serum. Porcine aortic smooth muscle cells were cultured for up to 28 days in medium in the absence (control) or presence of 2 mM phosphate ([P] positive calcification control) or after a single 3-day exposure to CNPs. Transmission electron-microscopy was used to characterize CNPs and to examine their cellular uptake. Calcium deposits were visualized by light microscopy and von Kossa staining and were quantified by colorimetry. Cell viability was quantified by confocal microscopy of live-/dead-stained cells and apoptosis was examined concurrently by fluorescent labeling of exposed phosphatidylserine.

resultsCNPs, as well as smaller calcium crystals, were observed by transmission electron-microscopy on day 3 in CNP-treated but not P-treated cells. By day 28, calcium deposits were visible in similar amounts within multicellular nodules of both CNP- and P-treated cells. Apoptosis increased with cell density under all treatments. CNP treatment augmented the density of apoptotic bodies and cellular debris in association with mineralized multicellular nodules.

conclusionExogenous CNPs are taken up by aortic smooth muscle cells in vitro and potentiate accumulation of smooth-muscle-derived apoptotic bodies at sites of mineralization. Thus, CNPs may accelerate vascular calcification.

Indexed as

AnimalsAtherosclerosisCalcifying NanoparticlesCalciumCells, CulturedHumansMuscle, Smooth, VascularMyocytes, Smooth MuscleSwineCalcifying NanoparticlesCalciumbiomineralizationhydroxyapatiteprotein-mineral complexvascular calcification

Identifiers

PMID24920905
PMCPMC4043721
OpenAlexW2086744948

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.